loadpatents
name:-0.045285940170288
name:-0.018722057342529
name:-0.00072884559631348
Larosa; Gregory J. Patent Filings

Larosa; Gregory J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Larosa; Gregory J..The latest application filed is for "opsin-binding ligands, compositions and methods of use".

Company Profile
0.15.29
  • Larosa; Gregory J. - Newton MA
  • Larosa; Gregory J. - West Roxbury MA
  • LaRosa; Gregory J - Newton MA
  • LaRosa; Gregory J. - Waban MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Opsin-binding Ligands, Compositions And Methods Of Use
App 20170137398 - Garvey; David S. ;   et al.
2017-05-18
Opsin-Binding Ligands, Compositions and Methods of Use
App 20170037018 - Garvey; David S. ;   et al.
2017-02-09
Opsin-binding ligands, compositions and methods of use
Grant 9,562,022 - Garvey , et al. February 7, 2
2017-02-07
Opsin-binding ligands, compositions and methods of use
Grant 9,499,464 - Garvey , et al. November 22, 2
2016-11-22
Humanized Anti-ccr2 Antibodies And Methods Of Use Therefor
App 20150086546 - Larosa; Gregory J. ;   et al.
2015-03-26
Humanized anti-CCR2 antibodies and methods of use therefor
Grant 8,926,971 - LaRosa , et al. January 6, 2
2015-01-06
Opsin-Binding Ligands, Compositions and Methods of Use
App 20140256782 - Garvey; David S. ;   et al.
2014-09-11
Humanized Anti-ccr2 Antibodies And Methods Of Use Therefor
App 20130071381 - LaRosa; Gregory J. ;   et al.
2013-03-21
Humanized anti-CCR2 antibodies and methods of use therefor
Grant 8,227,211 - LaRosa , et al. July 24, 2
2012-07-24
Opsin-binding ligands, compositions and methods of use
App 20110003784 - Garvey; David S. ;   et al.
2011-01-06
Humanized Anti-ccr2 Antibodies And Methods Of Use Therefor
App 20090191192 - LaRosa; Gregory J. ;   et al.
2009-07-30
Humanized anti-CCR2 antibodies and methods of use therefor
Grant 7,566,450 - LaRosa , et al. July 28, 2
2009-07-28
Anti-CCR2 antibodies and methods of use therefor
Grant 7,566,539 - LaRosa July 28, 2
2009-07-28
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
App 20090169541 - LaRosa; Gregory J. ;   et al.
2009-07-02
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
App 20090142339 - LaRosa; Gregory J. ;   et al.
2009-06-04
Humanized anti-CCR2 antibodies and methods of use therefor
Grant 7,473,421 - LaRosa , et al. January 6, 2
2009-01-06
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
App 20080268536 - LaRosa; Gregory J. ;   et al.
2008-10-30
Humanized anti-CCR2 antibodies and methods of use therefor
Grant 7,442,775 - LaRosa , et al. October 28, 2
2008-10-28
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
App 20080241136 - LaRosa; Gregory J. ;   et al.
2008-10-02
Humanized Anti-CCR2 Antibodies and Methods of Use Therefor
App 20080241923 - LaRosa; Gregory J. ;   et al.
2008-10-02
Anti-CCR2 antibodies and methods of use therefor
App 20050048052 - LaRosa, Gregory J.
2005-03-03
Anti-CCR2 antibodies and methods of use therefor
App 20040265303 - LaRosa, Gregory J. ;   et al.
2004-12-30
Humanized anti-CCR2 antibodies and methods of use therefor
App 20040132980 - LaRosa, Gregory J. ;   et al.
2004-07-08
Humanized anti-CCR2 antibodies and methods of use therefor
App 20040126851 - LaRosa, Gregory J. ;   et al.
2004-07-01
Imidazolidine compounds
App 20040127507 - Ohshima, Etsuo ;   et al.
2004-07-01
Imidazolidine compounds
App 20040122026 - Ohshima, Etsuo ;   et al.
2004-06-24
Recombinant anti-CCR2 antibodies and methods of use therefor
Grant 6,727,349 - LaRosa , et al. April 27, 2
2004-04-27
Humanized anti-CCR2 antibodies and methods of use therefor
Grant 6,696,550 - LaRosa , et al. February 24, 2
2004-02-24
Imidazolidine compounds
App 20030225288 - Ohshima, Etsuo ;   et al.
2003-12-04
Anti-CCR2 antibodies and methods of use therefor
App 20030165494 - LaRosa, Gregory J. ;   et al.
2003-09-04
Imidazolidine compounds
Grant 6,469,002 - Ohshima , et al. October 22, 2
2002-10-22
Anti-CCR2 antibodies and methods of use therefor
App 20020150570 - LaRosa, Gregory J.
2002-10-17
Humanized anti-CCR2 antibodies and methods of use therefor
App 20020150576 - LaRosa, Gregory J. ;   et al.
2002-10-17
Method of inhibiting cell function associated with CCR2 by anti-CCR2 amino-terminal domain antibodies
Grant 6,448,021 - LaRosa September 10, 2
2002-09-10
Anti-CCR2 antibodies
Grant 6,406,694 - LaRosa June 18, 2
2002-06-18
Anti-CCR2 antibodies and methods of use therefor
App 20020051781 - LaRosa, Gregory J.
2002-05-02
Anti-CCR2 antibodies and methods of use therefor
App 20020037285 - LaRosa, Gregory J.
2002-03-28
Anti-CCR2 antibodies and methods of use therefor
App 20020028436 - LaRosa, Gregory J.
2002-03-07
Anti-CCR2 antibodies and methods of use therefor
App 20020015700 - LaRosa, Gregory J.
2002-02-07
Anti-CCR2 antibodies and methods of use therefor
App 20020012664 - LaRosa, Gregory J.
2002-01-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed